WhitTier Trust Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.08M Sell
11,761
-46,139
-80% -$22.1M 0.11% 144
2026
Q1
$28.3M Buy
57,900
+3,367
+6% +$1.83M 0.58% 37
2025
Q4
$33.8M Sell
54,533
-1,130
-2% -$639K 0.7% 29
2025
Q3
$30.2M Buy
55,663
+13,904
+33% +$6.47M 0.64% 32
2025
Q2
$16.9M Buy
41,759
+570
+1% +$238K 0.38% 59
2025
Q1
$20.5M Buy
41,189
+602
+1% +$326K 0.52% 47
2024
Q4
$21.1M Buy
40,587
+1,785
+5% +$981K 0.52% 45
2024
Q3
$24M Sell
38,802
-437
-1% -$259K 0.62% 35
2024
Q2
$21.7M Buy
39,239
+462
+1% +$265K 0.6% 39
2024
Q1
$22.5M Buy
38,777
+925
+2% +$519K 0.65% 34
2023
Q4
$20.1M Sell
37,852
-8
-0% -$3.87K 0.64% 34
2023
Q3
$19.2M Sell
37,860
-126
-0.3% -$67.1K 0.68% 34
2023
Q2
$19.8M Buy
37,986
+40
+0.1% +$21.6K 0.67% 31
2023
Q1
$21.9M Buy
37,946
+1,586
+4% +$894K 0.8% 26
2022
Q4
$20M Sell
36,360
-236
-0.6% -$125K 0.79% 30
2022
Q3
$18.6M Buy
36,596
+277
+0.8% +$155K 0.79% 26
2022
Q2
$19.7M Buy
36,319
+1,897
+6% +$1.04M 0.81% 27
2022
Q1
$20.3M Buy
34,422
+3,118
+10% +$1.79M 0.74% 30
2021
Q4
$20.9M Buy
31,304
+1,554
+5% +$970K 0.76% 28
2021
Q3
$17M Buy
29,750
+891
+3% +$489K 0.7% 32
2021
Q2
$14.6M Sell
28,859
-219
-0.8% -$103K 0.61% 35
2021
Q1
$13.3M Buy
29,078
+1,358
+5% +$648K 0.59% 40
2020
Q4
$12.9M Buy
27,720
+381
+1% +$179K 0.65% 36
2020
Q3
$12.1M Buy
27,339
+308
+1% +$127K 0.7% 32
2020
Q2
$9.79M Buy
27,031
+3,461
+15% +$1.16M 0.62% 39
2020
Q1
$6.68M Buy
23,570
+2,197
+10% +$693K 0.51% 54
2019
Q4
$6.94M Buy
21,373
+1,004
+5% +$304K 0.44% 64
2019
Q3
$5.93M Buy
20,369
+559
+3% +$160K 0.41% 66
2019
Q2
$5.82M Buy
19,810
+147
+0.7% +$40.5K 0.41% 68
2019
Q1
$5.38M Buy
19,663
+700
+4% +$174K 0.4% 68
2018
Q4
$4.24M Buy
18,963
+537
+3% +$126K 0.35% 77
2018
Q3
$4.5M Buy
18,426
+1,502
+9% +$346K 0.33% 82
2018
Q2
$3.5M Buy
16,924
+3,365
+25% +$714K 0.27% 95
2018
Q1
$2.8M Buy
13,559
+3,312
+32% +$695K 0.23% 111
2017
Q4
$1.95M Sell
10,247
-508
-5% -$97.3K 0.17% 132
2017
Q3
$2.04M Buy
10,755
+17
+0.2% +$3.08K 0.19% 122
2017
Q2
$1.87M Hold
10,738
0.18% 129
2017
Q1
$1.65M Sell
10,738
-50
-0.5% -$7.64K 0.16% 136
2016
Q4
$1.52M Sell
10,788
-320
-3% -$47.2K 0.16% 135
2016
Q3
$1.77M Sell
11,108
-115
-1% -$17.7K 0.2% 115
2016
Q2
$1.66M Sell
11,223
-55
-0.5% -$8.12K 0.19% 121
2016
Q1
$1.6M Sell
11,278
-250
-2% -$33.5K 0.19% 125
2015
Q4
$1.64M Sell
11,528
-310
-3% -$41.3K 0.19% 126
2015
Q3
$1.45M Buy
11,838
+1,550
+15% +$202K 0.18% 127
2015
Q2
$1.33M Sell
10,288
-40
-0.4% -$5.21K 0.15% 147
2015
Q1
$1.39M Hold
10,328
0.15% 140
2014
Q4
$1.29M Hold
10,328
0.14% 148
2014
Q3
$1.26M Sell
10,328
-35
-0.3% -$4.26K 0.14% 145
2014
Q2
$1.22M Sell
10,363
-1,215
-10% -$143K 0.14% 156
2014
Q1
$1.39M Hold
11,578
0.16% 134
2013
Q4
$1.29M Sell
11,578
-182
-2% -$18.1K 0.16% 133
2013
Q3
$1.08M Hold
11,760
0.15% 146
2013
Q2
$995K Buy
+11,760
New +$979K 0.14% 140

Other funds holding TMO

WhitTier Trust Company's TMO Position: Q2 2026 in Review

WhitTier Trust Company reduced its Thermo Fisher Scientific (TMO) stake by 80% in Q2 2026, selling an estimated $22.1M and leaving 11,761 shares worth $6.08M. The position accounts for 0.11% of the portfolio, ranked #144.

WhitTier Trust Company first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $33.8M in Q4 2025. 1,170 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • WhitTier Trust Company held 11,761 shares of Thermo Fisher Scientific worth $6.08M as of Q2 2026.
  • WhitTier Trust Company sold 46,139 Thermo Fisher Scientific shares in Q2 2026, an estimated $22.1M.
  • Thermo Fisher Scientific made up 0.11% of WhitTier Trust Company's portfolio in Q2 2026, its #144 holding.
  • WhitTier Trust Company first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • WhitTier Trust Company's Thermo Fisher Scientific position peaked at $33.8M in Q4 2025.
  • 1,170 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.